General hospital psychiatry最新文献

英文中文

More than just therapy: Building a sustainable model for suicide prevention

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-30 DOI: 10.1016/j.genhosppsych.2025.01.018

Yetty Morelent , Santi Tri Meilina , Hidayati Azkiya , Elvima Nofrianni , Sumianto , Willa Putri , Dhini Mufti , Aldora Pratama , Ramtia Darma Putri , Erfan Ramadhani

引用次数: 0

Clarifying the impact of E-cigarettes on mental health: What's next?

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-30 DOI: 10.1016/j.genhosppsych.2025.01.020

Donal , Santi Tri Meilina , Afdhal Ilahi , Nurbaiti , Aldora Pratama , Ramtia Darma Putri , Arief Kuswidyanarko , Dony Darma Sagita , Erfan Ramadhani

引用次数: 0

Revisiting the lorazepam challenge: An algorithm for clinical-decision making

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-28 DOI: 10.1016/j.genhosppsych.2025.01.016

Matthew Gunther , James Luccarelli , Scott Beach

引用次数: 0

Psychological inflexibility and its impact on mental health and quality of life: Expanding insights and interventions

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-27 DOI: 10.1016/j.genhosppsych.2025.01.015

Paul Arjanto, Vando Kristi Makaruku

引用次数: 0

Letter to the editor concerning: Risk of agranulocytosis and neutropenia in patients with Parkinson's disease psychosis receiving clozapine treatment: A systematic review and meta-analysis. Limveeraprajak N, Makkapavee W, Likhitsathian S, Srisurapanont M. Possibly a greater risk? 致编辑的信关于：接受氯氮平治疗的帕金森病精神病患者粒细胞缺乏症和中性粒细胞减少症的风险：一项系统回顾和荟萃分析。Limveeraprajak N, Makkapavee W, Likhitsathian S, Srisurapanont M.可能风险更大？

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-19 DOI: 10.1016/j.genhosppsych.2025.01.010

Joseph H. Friedman

引用次数: 0

Breaking barriers in emergency care: Advancing equity for patients with severe mental illness 打破急诊护理中的障碍：促进严重精神疾病患者的公平待遇。

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-17 DOI: 10.1016/j.genhosppsych.2025.01.012

Paul Arjanto , Mint Husen Raya Aditama , Feibry Feronika Wiwenly Senduk

引用次数: 0

Effect of e-cigarettes for smoking cessation on depressive and anxiety symptoms: Secondary analysis of a randomized controlled trial 电子烟戒烟对抑郁和焦虑症状的影响：一项随机对照试验的二次分析。

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-16 DOI: 10.1016/j.genhosppsych.2025.01.011

Anna Rihs , Anna Schoeni , Tamara Scharf , Julian Jakob , Kali Tal , Isabelle Jacot-Sadowski , Jean-Paul Humair , Anja Frei , Martin Brutsche , Nicolas Rodondi , Reto Auer , Stéphanie Baggio

Objective

This study aims to assess differences in depressive and anxiety symptoms at 6-month follow-up in a smoking cessation trial using e-cigarettes as quitting aids.

Methods

We conducted a secondary analysis of the Swiss multicentre ESTxENDS smoking cessation randomized controlled trial (RCT) assessing differences in depressive (Patient Health Questionnaire-9, PHQ-9, range: 0–27) and anxiety symptoms (General Anxiety Disorder-7, GAD-7, range: 0–21) at 6-month follow-up comparing participants who received e-cigarettes to those who received smoking cessation counseling alone.

Results

Of 1244 participants 913 completed the PHQ-9 and 884 the GAD-7 at 6-month follow-up. Mean PHQ-9 scores (SD) at 6 months for the intervention group were 3.7 (3.9), control group: 4.0 (4.2); mean GAD-7 scores (SD) at 6 months for the intervention group were 4.6 (4.3), control group: 4.6 (4.4). Multivariable analyses showed no evidence of a clinically relevant intervention effect on the PHQ-9 [coefficient − 0.101, 95 % CI -0.182 to −0.019, p = .016, corresponding to a 0.9 decrease of the original PHQ-9 score] and the GAD-7 scores [coefficient − 0.056, 95 % CI -0.135 to 0.022, p = .160] in the main adjusted models.

Conclusions

Among smokers who participated in the ESTxENDS smoking cessation trial, we found distribution of e-cigarettes for smoking cessation in addition to standard counseling compared to counseling alone had no clinically relevant effect on depressive or anxiety symptoms at 6-month follow-up.

Trial Registration: ClinicalTrials NCT03603340

目的：本研究旨在评估使用电子烟作为戒烟辅助的戒烟试验中6个月随访期间抑郁和焦虑症状的差异。方法：我们对瑞士多中心ESTxENDS戒烟随机对照试验（RCT）进行了二次分析，评估在6个月的随访中，接受电子烟治疗的参与者与单独接受戒烟咨询的参与者在抑郁（患者健康问卷-9，PHQ-9，范围：0-27）和焦虑症状（一般焦虑障碍-7，GAD-7，范围：0-21）方面的差异。结果：在6个月的随访中，1244名参与者中913名完成了PHQ-9, 884名完成了GAD-7。干预组6个月平均PHQ-9评分（SD） 3.7分（3.9分），对照组4.0分（4.2分）；干预组6个月时GAD-7平均评分（SD） 4.6分（4.3分），对照组4.6分（4.4分）。多变量分析显示，在主要调整模型中，没有证据表明临床相关干预对PHQ-9[系数- 0.101,95% CI -0.182至-0.019,p = 0.016，对应于原始PHQ-9评分降低0.9]和GAD-7评分[系数- 0.056,95% CI -0.135至0.022,p = 0.160]有影响。结论：在参加ESTxENDS戒烟试验的吸烟者中，我们发现在6个月的随访中，在标准咨询的基础上分发戒烟电子烟与单独咨询相比，对抑郁或焦虑症状没有临床相关的影响。试验注册：ClinicalTrials NCT03603340。

{"title":"Effect of e-cigarettes for smoking cessation on depressive and anxiety symptoms: Secondary analysis of a randomized controlled trial","authors":"Anna Rihs , Anna Schoeni , Tamara Scharf , Julian Jakob , Kali Tal , Isabelle Jacot-Sadowski , Jean-Paul Humair , Anja Frei , Martin Brutsche , Nicolas Rodondi , Reto Auer , Stéphanie Baggio","doi":"10.1016/j.genhosppsych.2025.01.011","DOIUrl":"10.1016/j.genhosppsych.2025.01.011","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to assess differences in depressive and anxiety symptoms at 6-month follow-up in a smoking cessation trial using e-cigarettes as quitting aids.</div></div><div><h3>Methods</h3><div>We conducted a secondary analysis of the Swiss multicentre ESTxENDS smoking cessation randomized controlled trial (RCT) assessing differences in depressive (Patient Health Questionnaire-9, PHQ-9, range: 0–27) and anxiety symptoms (General Anxiety Disorder-7, GAD-7, range: 0–21) at 6-month follow-up comparing participants who received e-cigarettes to those who received smoking cessation counseling alone.</div></div><div><h3>Results</h3><div>Of 1244 participants 913 completed the PHQ-9 and 884 the GAD-7 at 6-month follow-up. Mean PHQ-9 scores (SD) at 6 months for the intervention group were 3.7 (3.9), control group: 4.0 (4.2); mean GAD-7 scores (SD) at 6 months for the intervention group were 4.6 (4.3), control group: 4.6 (4.4). Multivariable analyses showed no evidence of a clinically relevant intervention effect on the PHQ-9 [coefficient − 0.101, 95 % CI -0.182 to −0.019, <em>p</em> = .016, corresponding to a 0.9 decrease of the original PHQ-9 score] and the GAD-7 scores [coefficient − 0.056, 95 % CI -0.135 to 0.022, <em>p</em> = .160] in the main adjusted models.</div></div><div><h3>Conclusions</h3><div>Among smokers who participated in the ESTxENDS smoking cessation trial, we found distribution of e-cigarettes for smoking cessation in addition to standard counseling compared to counseling alone had no clinically relevant effect on depressive or anxiety symptoms at 6-month follow-up.</div><div>Trial Registration: ClinicalTrials <span><span>NCT03603340</span><svg><path></path></svg></span></div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 67-72"},"PeriodicalIF":4.1,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Depression recovery: Untangling the effects of childhood trauma 抑郁症的恢复：解开童年创伤的影响。

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-13 DOI: 10.1016/j.genhosppsych.2025.01.008

Ali Fakhrudin , Aziziyah Munawaroh , Donal , Ramtia Darma Putri , Erfan Ramadhani , Safta Hastini , Aldora Pratama , Anna Ayu Herawati

引用次数: 0

The effect of inpatient brief cognitive-behavioral therapy for suicide prevention on post-discharge emergency department utilization: Secondary analysis of a randomized clinical trial 预防自杀的住院短暂认知行为治疗对出院后急诊使用率的影响：一项随机临床试验的二次分析

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-13 DOI: 10.1016/j.genhosppsych.2025.01.007

Gretchen J. Diefenbach , Sarah Collett , Sonata Black , M. David Rudd , Ralitza Gueorguieva , David F. Tolin

Objective

Diefenbach and colleagues (2024) found that inpatient Brief Cognitive-Behavioral Therapy for Suicide Prevention (BCBT-I) reduced the rate of six-month post-discharge psychiatric readmissions compared to treatment as usual (TAU). This treatment effect; however, was limited to inpatients, whom were not diagnosed with substance use disorder (SUD). The aim of this secondary analysis was to determine BCBT-I treatment effects and SUD moderation on post-discharge emergency department (ED) utilization.

Methods

Inpatients with a history of suicide attempt were assigned to BCBT-I + TAU (n = 94) or TAU alone (n = 106). Presence and number of ED visits were determined via self-report and electronic medical record review for six months after discharge. Generalized linear models for count and binary data were conducted.

Results

Adding BCBT-I to TAU reduced the odds and rate of post-discharge ED visits by three quarters [Odds Ratio estimate = 0.25, 95 % CI:(0.12, 0.46); Rate Ratio estimate = 0.24, 95 % CI:(0.11, 0.53)], but only among participants without SUD. Over one-third (36 %) of ED visits were related to suicide. Findings for suicide-related ED visits mirrored those of all-cause ED visits.

Conclusions

Adding BCBT-I to TAU reduced post-discharge ED utilization in participants without SUD. Additional research is needed to improve the efficacy of BCBT-I for patients with SUD.

目的：Diefenbach及其同事（2024）发现，与常规治疗（TAU）相比，住院患者短暂自杀预防认知行为疗法（BCBT-I）降低了出院后6个月精神科再入院率。这种治疗效果；然而，该研究仅限于未被诊断为物质使用障碍（SUD）的住院患者。本二次分析的目的是确定BCBT-I治疗效果和SUD调节对出院后急诊科（ED）利用的影响。方法：将有自杀企图史的住院患者分为BCBT-I + TAU组（n = 94）和单独TAU组（n = 106）。通过出院后6个月的自我报告和电子病历审查来确定急诊科的存在和就诊次数。建立了计数和二进制数据的广义线性模型。结果：将BCBT-I加入TAU可使出院后急诊科就诊的几率和率降低四分之三[优势比估计= 0.25,95% CI:(0.12, 0.46)；率比估计= 0.24,95% CI:(0.11, 0.53)]，但仅在没有SUD的参与者中。超过三分之一（36%）的急诊室就诊与自杀有关。与自杀相关的急诊科就诊的结果与全因急诊科就诊的结果一致。结论：在TAU中加入BCBT-I可降低无SUD受试者的出院后ED使用率。需要进一步的研究来提高BCBT-I对SUD患者的疗效。

{"title":"The effect of inpatient brief cognitive-behavioral therapy for suicide prevention on post-discharge emergency department utilization: Secondary analysis of a randomized clinical trial","authors":"Gretchen J. Diefenbach , Sarah Collett , Sonata Black , M. David Rudd , Ralitza Gueorguieva , David F. Tolin","doi":"10.1016/j.genhosppsych.2025.01.007","DOIUrl":"10.1016/j.genhosppsych.2025.01.007","url":null,"abstract":"<div><h3>Objective</h3><div>Diefenbach and colleagues (2024) found that inpatient Brief Cognitive-Behavioral Therapy for Suicide Prevention (BCBT-I) reduced the rate of six-month post-discharge psychiatric readmissions compared to treatment as usual (TAU). This treatment effect; however, was limited to inpatients, whom were not diagnosed with substance use disorder (SUD). The aim of this secondary analysis was to determine BCBT-I treatment effects and SUD moderation on post-discharge emergency department (ED) utilization.</div></div><div><h3>Methods</h3><div>Inpatients with a history of suicide attempt were assigned to BCBT-I + TAU (<em>n</em> = 94) or TAU alone (<em>n</em> = 106). Presence and number of ED visits were determined via self-report and electronic medical record review for six months after discharge. Generalized linear models for count and binary data were conducted.</div></div><div><h3>Results</h3><div>Adding BCBT-I to TAU reduced the odds and rate of post-discharge ED visits by three quarters [Odds Ratio estimate = 0.25, 95 % CI:(0.12, 0.46); Rate Ratio estimate = 0.24, 95 % CI:(0.11, 0.53)], but only among participants without SUD. Over one-third (36 %) of ED visits were related to suicide. Findings for suicide-related ED visits mirrored those of all-cause ED visits.</div></div><div><h3>Conclusions</h3><div>Adding BCBT-I to TAU reduced post-discharge ED utilization in participants without SUD. Additional research is needed to improve the efficacy of BCBT-I for patients with SUD.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 73-79"},"PeriodicalIF":4.1,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

BREDS: Advancing eating disorder screening potential and challenges 促进饮食失调筛查的潜力和挑战。

IF 4.1 2区医学 Q1 PSYCHIATRY

General hospital psychiatry

Pub Date : 2025-01-13 DOI: 10.1016/j.genhosppsych.2025.01.009

Rikas Saputra , Yenni Lidyawati

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

General hospital psychiatry

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀